A 2013 study analyzed a group of 358 cases of grade 4 gliomas, of which 322 were GBM (IDH-Wildtype) and 36 were IDH-Mutant grade 4 astrocytoma. This evidence concerns the gene IDH1 and central nervous system cancer.